Companies similar to MYRIAD GENETICS INC (MYGN)
Health Care · NASDAQ
MYRIAD GENETICS INC (MYGN)'s closest peers include Guardant Health, Inc. (GH), Natera (NTRA), Illumina, Inc. (ILMN), Labcorp (LH) and Quest Diagnostics (DGX). This peer set is drawn from MYGN's enriched company profile and is informational only — not financial advice.
Similar companies
-
Guardant Health, Inc.GHHealth Care
Guardant Health is a precision oncology company transforming cancer care with FDA-approved blood and tissue tests powered by AI analytics that span early…
$152.29 (as of 2026-07-21) · market cap $20.1B
-
NateraNTRAHealth Care
Natera uses proprietary blood-based cell-free DNA technology to deliver personalized genetic diagnostics for oncology, prenatal screening, and organ transplant…
$267.18 (as of 2026-07-21) · market cap $38.1B
-
Illumina, Inc.ILMNHealth Care
Illumina is the global leader in DNA sequencing and array technologies that are foundational to modern genomics research and clinical diagnostics.
$192.53 (as of 2026-07-21) · market cap $28.8B
-
LabcorpLHHealth Care
A global diagnostics and drug development laboratory leader that performs 750+ million clinical tests annually and supports 85% of new FDA-approved drugs…
$279.40 (as of 2026-07-21) · market cap $22.9B
-
Quest DiagnosticsDGXHealth Care
Quest Diagnostics is the largest clinical laboratory testing company in the U.S., providing diagnostic insights to healthcare providers, employers, and…
$206.84 (as of 2026-07-21) · market cap $22.8B
Not quite? Describe exactly what you want →
Peers are drawn from MYGN's enriched profile (the same similarity signal the chat uses for "companies like MYGN"). See the full profile: MYRIAD GENETICS INC (MYGN).
Last updated 2026-07-21.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.